Rejane Maria Rodrigues de Abreu Vieira

Hospital Geral de Fortaleza · CE · 24 publicações em 2022–2026

SARS-CoV-2 and COVID-19 ResearchRheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus ResearchCOVID-19 Clinical Research StudiesVaccine Coverage and Hesitancy

Principais coautores no Nordeste tamanho = publicações em comum

Ana Karla Guedes de Melo Cláudia Diniz Lopes Marques Adah Sophia Rodrigues Vieira T. Santos Melo Tâmara Santos Melo Lílian David de Azevedo Valadares Nara Gualberto Cavalcanti Alessandra de Sousa Braz Carlos Ewerton Maia Rodrigues Danielle Christinne Soares Egypto de Brito Fabio Tavora J. M. C. Fernandes

Publicações recentes

2026 5

Immunogenicity and safety of BNT162b2 vaccine in patients with juvenile immune mediated inflammatory disease
Medicina · Pediatric Research
Leprosy masquerading as systemic lupus erythematosus: a case report and systematic review of the literature
Medicina · Revista Brasileira de Reumatologia
Impact of sex in axial spondyloarthritis: insights from the Brazilian Registry of Spondyloarthritis
Medicina · Revista Brasileira de Reumatologia
Brazilian Society of Rheumatology – 2025 recommendations on vaccination in immune-mediated rheumatic diseases
Medicina · Revista Brasileira de Reumatologia
Beyond strongyloides: rationale for empirical antiparasitic prophylaxis in immunosuppressed patients with rheumatic diseases in endemic areas
Imunologia e microbiologia · Revista Brasileira de Reumatologia

2025 7

Brazilian recommendations for the management of tuberculosis infection in immune-mediated inflammatory diseases
Medicina · Revista Brasileira de Reumatologia
Comparison of the immunogenicity and safety among COVID-19 vaccines ChadOx-1, CoronaVac and BNT162b2 in systemic lupus erythematosus (SLE) patients: a prospective cohort
Medicina · Revista Brasileira de Reumatologia
Immunogenicity and safety to SARS-Cov-2 vaccination in patients with systemic vasculitis
Medicina · Frontiers in Immunology
Reply to the letter on “Brazilian guidelines for the management of tuberculosis infection in immune-mediated inflammatory diseases: is retesting in latent tuberculosis screening appropriate and safe?”
Medicina · Revista Brasileira de Reumatologia
Correction: Brazilian recommendations for the management of tuberculosis infection in immune-mediated inflammatory diseases
Medicina · Revista Brasileira de Reumatologia
Impact of SARS-CoV-2 Vaccination on Disease Activity and Severity of COVID-19 Infection in Patients with Systemic Lupus Erythematosus: A Multicenter Cohort Study
Medicina · Vaccines
SAFETY PROFILE OF VACCINES AGAINST SARS-COV-2 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA FROM PROSPECTIVE MULTICENTRIC STUDY - SAFER STUDY
Medicina · The Journal of Rheumatology

2024 6

To be or not to B27 positive: implications for the phenotypes of axial spondyloarthritis outcomes. Data from a large multiracial cohort from the Brazilian Registry of Spondyloarthritis
Medicina · Revista Brasileira de Reumatologia
Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer
Medicina · Revista Brasileira de Reumatologia
Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort
Medicina · Vaccines
AB0078 PREDICTORS OF HOSPITALIZATION DUE TO BREAKTHROUGH COVID-19 INFECTION IN PATIENTS WITH IMMUNE-MEDIATED RHEUMATIC DISEASES: DATA FROM SAFER STUDY
Medicina · Annals of the Rheumatic Diseases
AB0581 BIVALENT MRNA COVID-19 VACCINE BOOSTER DOES NOT INCREASE THE RISK OF FLARE IN RHEUMATOID ARTHRITIS PATIENTS UNDER REAL LIFE SETTING – DATA FROM SAFER STUDY
Medicina · Annals of the Rheumatic Diseases
POS0572 FACTORS ASSOCIATED WITH VACCINE RESPONSE AFTER COVID VACCINE BOOSTER IN PATIENTS WITH AUTOIMMUNE DISEASES: DATA FROM MULTICENTRIC PROSPECTIVE PHASE IV SAFER STUDY
Medicina · Annals of the Rheumatic Diseases

2023 3

POS0271 HETEROLOGOUS COVID-19 BOOSTER VACCINATION PRODUCED GREATER ANTIBODY TITERS IN AUTOIMMUNE DISEASE PATIENTS: DATA FROM MULTICENTRIC PROSPECTIVE PHASE IV SAFER STUDY
Medicina · Annals of the Rheumatic Diseases
AB1316 SAFETY AND IMMUNOGENICITY OF TWO HETEROLOGOUS VACCINE SCHEDULES AGAINST SARS-CoV-2 IN PATIENTS WITH RHEUMATOID ARTHRITIS: BRAZILIAN MULTICENTER STUDY
Medicina · Annals of the Rheumatic Diseases
POS0274 PROSPECTIVE EVALUATION OF THE EFFECT OF THE VACCINE AGAINST SARS-COV-2 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA FROM SAFER STUDY
Medicina · Annals of the Rheumatic Diseases

2022 3

Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force
Medicina · Revista Brasileira de Reumatologia
How Did Patients Living With Immune-Mediated Rheumatic Diseases Face the Beginning of the COVID-19 Pandemic in Brazil? Results of the COnVIDa Study
Medicina · JCR Journal of Clinical Rheumatology
Valores humanísticos importantes na formação do profissional médico: o que pensam os estudantes e professores
Medicina · Research Society and Development

Contagens só com publicações em revistas com Qualis (filtro na tela inicial). Dados obtidos de fontes abertas: OpenAlex (CC0), ROR (CC0), CAPES Dados Abertos (CC-BY), INEP e IBGE. Encontrou um erro sobre você? Saiba mais. Criado por Gabriel Pina.